SRSF1 and pancreatic neoplasm: Silencing SRSF1 restored splicing of MNK2 to the canonical MNK2a variant, led to decreased phosphorylation of eIF4E and increased the sensitivity of pancreatic cancer cells to gemcitabine treatment [264].